Dabigatran reversal
Indications
Idarucizumab is indicated for the reversal of life-threatening or uncontrolled bleeding or when emergency surgery or urgent procedures are required.
Prothrombin complex concentrate
Despite these limitations and the fact that prothrombin complex concentrates and aPCCs are not yet licensed for dabigatran reversal, their use appears to be warranted in patients with life-threatening haemorrhage if idarucizumab is not available.